| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.08. | Simris Group AB: Simris Group Interim Report January-june 2026 | 183 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2026Net revenue decreased by 71% to SEK 196k (687k).EBITDA improved by 35% to SEK -1 927k (-2 980k).EBIT/Operating result improved by 19% to SEK -5 437k (-6 693k).INTERIM PERIOD... ► Artikel lesen | |
| 15.07. | Simris Group AB: Simris Group Ab Appoints Adc Expert Professor Andreas Pahl As Chief Executive Officer Of Its Subsidiary Simris Biologics Gmbh | 393 | GlobeNewswire (Europe) | Simris Group AB (SIMRIS B) today announced the appointment of Professor Andreas Pahl as Chief Executive Officer of Simris Biologics GmbH, its wholly owned subsidiary based in Berlin, Germany. Professor... ► Artikel lesen | |
| 24.06. | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 253 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 24 June 2026. Below follows a summary of the resolutions that were passed at the general meeting
Income... ► Artikel lesen | |
| 13.05. | Simris Group AB: Simris Group Interim Report January-march 2026 | 294 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2026Net revenue increased by 167% to SEK 424k (159k).EBITDA improved by 41% to SEK -2 183k (-3 724k).EBIT/Operating result improved by 23% to SEK -5 626k (-7 288k).KEY EVENTS... ► Artikel lesen | |
| 12.05. | Simris Group AB: Simris Group Advances Asset Divestment Process with Two Prospective Buyers | 473 | GlobeNewswire (Europe) | Simris Group AB (Simris or the Company) today announces progress in its strategic divestment process for its microalgae production facility in Hammenhög, Sweden. Simris has entered into a Memorandum... ► Artikel lesen | |
| 11.03. | Simris Group AB: Simis provides an update on the divestment of its assets in Hammenhög, Sweden | 261 | GlobeNewswire (Europe) | Simris Group AB ("Simris" or the "Company") announces that discussions with Immunrise Biocontrol France SAS ("Immunrise") continue, on a non-exclusive basis, beyond the deadline of March 1, 2026 and... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 28.02. | Simris Group AB: Simris Group Year-end Report January-december 2025 | 580 | GlobeNewswire (Europe) | QUARTER 4, JULY - DECEMBER 2025Net revenue decreased by 71% to SEK 285k (971k).EBITDA declined by 63% to SEK -5 196k (-3 180k).EBIT/Operating result improved by 9% to SEK -8 429 (-9 241k).YEAR-END PERIOD... ► Artikel lesen | |
| 19.01. | Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting | 381 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting.
Election... ► Artikel lesen | |
| 12.11.25 | Simris Group AB receives observation status | 312 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11.25 | Simris Group AB: Simris Group Interim Report January-september 2025 | 346 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11.25 | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 429 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11.25 | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 326 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10.25 | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 400 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 8,925 | +1,19 % | US judge cuts Beyond Meat trademark penalty | ||
| OATLY GROUP | 10,650 | 0,00 % | Oatly AB: Oatly Group AB (publ) Announces Results of 2026 Annual General Meeting | MALMÖ, Sweden, May 20, 2026 (GLOBE NEWSWIRE) -- Oatly Group AB (publ) (Nasdaq: OTLY) ("Oatly" or the "Company"), the world's original and largest oat drink company, today announced the results of... ► Artikel lesen | |
| CONAGRA BRANDS | 13,025 | +0,31 % | Conagra Brands declares $0.175 quarterly dividend | ||
| AGRARIUS | - | - | Agrarius AG: "Wende zur schwarzen Null nahezu geschafft - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | im Anhang finden Sie den HV-Bericht zur Gesellschaft von der GSC Research GmbHAnhang: HVAGRARIUS2026.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 85,14 | -1,05 % | Raymond James cuts Wingstop stock price target on valuation metrics | ||
| WH GROUP | 0,747 | +3,52 % | WH GROUP (00288): 2026 INTERIM REPORT | ||
| MHP | 6,000 | 0,00 % | Ukraine-Spain Business Council Holds Inaugural Meeting; Ukrainian Chapter Led by MHP Executive | KYIV, Ukraine, July 16, 2026 /PRNewswire/ -- The inaugural meeting of the Ukraine-Spain Business Council was held in Kyiv. The Ukrainian chapter of the Council is chaired by Mykhailo Bno-Airiian... ► Artikel lesen | |
| JACK IN THE BOX | 11,800 | -0,84 % | Jack in the Box appoints former Starbucks CFO to board | ||
| J&J SNACK FOODS | 68,00 | +1,49 % | Dividendenbekanntmachungen (15.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKVA GROUP ASA NO0003097503 1 NOK 0,0927 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,35 EUR ALTRIA GROUP INC US02209S1033 1,11 USD 0... ► Artikel lesen | |
| ELSE NUTRITION | 0,036 | -18,33 % | XFRA 0YL1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| BIOGAIA | 10,200 | +4,35 % | BioGaia AB will launch a new clinically proven probiotic to support colon health | BioGaia announces the launch of BioGaia® Colus®, a probiotic formulation designed to promote colon health through a strain-specific and targeted delivery approach. The product expands BioGaia's science-based... ► Artikel lesen | |
| CAVA GROUP | 53,13 | +0,02 % | Cava opens 500th restaurant, ahead of schedule for 1,000 by 2032 | ||
| MCDONALDS | 210,50 | +0,53 % | UBS stuft MCDONALDS auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für McDonald's vor einer Investorenveranstaltung der Restaurantkette von 340 auf 320 US-Dollar gesenkt, aber die Einstufung auf... ► Artikel lesen | |
| FIRST WATCH RESTAURANT GROUP | 10,200 | 0,00 % | First Watch drosselt Expansion und setzt auf Cashflow | ||
| SWEETGREEN | 7,720 | 0,00 % | Anleger verlieren den Appetit: Krankheitsausbruch in den USA reißt Restaurant-Aktien runter | © Foto: Guillermo Arias - APAktien von Cava, Chipotle und Sweetgreen rutschen ab, bei Taco Bell brechen die Besucherzahlen ein. Ein Cyclospora-Ausbruch in den USA wird plötzlich zum Börsenproblem. Ein... ► Artikel lesen |